EGF and Alzheimer disease: In this regard, although EGF (5ppm) did not show a better effect than EGF (1ppm) treatment on PAR-2 and TSLP expression, our findings indicate that EGF can ameliorate itching as well as the immune response by inhibiting PAR-2 and TSLP expression in AD lesions.